Irritation and Anal Bleeding in Patients Affected by Hemorrhoids.
Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
Haemorrhoidal disease is an increasingly frequent benign condition, able to negatively affect
the quality of working and relationship life in affected individuals.The primary objective of
the study is the comparative assessment of the time necessary for the disappearance of
bleeding comparatively in the three different therapies (controls, ProtFlav and ProtCent) to
identify, if any, the most effective treatment, in terms of time reduction for the
disappearance of bleeding in subjects affected by haemorrhoidal disease.
Patients enrolled will be randomized into 3 groups:
1. the control group in which the patients will be subjected to the standard therapeutic
care (diet rich in water and vegetable fibers, hygienic),
2. interventional group "ProtFlav": in which oral supplements (flavonoid-based supplements
- ProtFlav) will be added to standard of care
3. interventional group "ProtCent": in which an anal application of a Centella based cream
(Centella asiatica - ProtCent) will be added to standard of care